POLOCAINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Polocaine, and what generic alternatives are available?
Polocaine is a drug marketed by Dentsply Pharm and Fresenius Kabi Usa and is included in seven NDAs.
The generic ingredient in POLOCAINE is levonordefrin; mepivacaine hydrochloride. There are two drug master file entries for this compound. Additional details are available on the levonordefrin; mepivacaine hydrochloride profile page.
Summary for POLOCAINE
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 7 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 100 |
Patent Applications: | 5,077 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for POLOCAINE |
DailyMed Link: | POLOCAINE at DailyMed |
Pharmacology for POLOCAINE
Drug Class | Amide Local Anesthetic |
Physiological Effect | Local Anesthesia |